Introduction Executive Summary Basal cell carcinoma: Overview • Causes • Mechanism of Action • Signs and Symptoms • Diagnosis • Disease Management Pipeline Therapeutics • Comparative Analysis Therapeutic Assessment • Assessment by Product Type • Assessment by Stage and Product Type • Assessment by Route of Administration • Assessment by Stage and Route of Administration • Assessment by Molecule Type • Assessment by Stage and Molecule Type Basal cell carcinoma – DelveInsight’s Analytical Perspective In-depth Commercial Assessment • Basal cell carcinoma companies’ collaborations, Licensing, Acquisition -Deal Value Trends Basal cell carcinoma Collaboration Deals • Company-Company Collaborations (Licensing / Partnering) Analysis • Company-University Collaborations (Licensing / Partnering) Analysis Late Stage Products (Phase III) • Comparative Analysis Patidegib: PellePharm • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Mid Stage Products (Phase II) • Comparative Analysis IO103: IO Biotech • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Early Stage Products (Phase I) • Comparative Analysis Silmitasertib: Senhwa Biosciences • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Preclinical and Discovery Stage Products • Comparative Analysis GT 1708F: Suzhou Kintor Pharmaceuticals • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Inactive Products • Comparative Analysis Basal cell carcinoma Key Companies Basal cell carcinoma Key Products Basal cell carcinoma- Unmet Needs Basal cell carcinoma- Market Drivers and Barriers Basal cell carcinoma- Future Perspectives and Conclusion Basal cell carcinoma Analyst Views Basal cell carcinoma Key Companies Appendix

Table 1 Total Products for Basal cell carcinoma Table 2 Late Stage Products Table 3 Mid Stage Products Table 4 Early Stage Products Table 5 Pre-clinical & Discovery Stage Products Table 6 Assessment by Product Type Table 7 Assessment by Stage and Product Type Table 8 Assessment by Route of Administration Table 9 Assessment by Stage and Route of Administration Table 10 Assessment by Molecule Type Table 11 Assessment by Stage and Molecule Type Table 12 Inactive Products

• PellePharm • IO Biotech • Sirnaomics • Aresus Pharma • Epitome Pharmaceuticals • AiViva BioPharma • Kintara Therapeutics • Transgene • Senhwa Biosciences • Palvella Therapeutics • Suzhou Kintor Pharmaceuticals • Leaf Vertical